Executives of Top Pharmacy Benefit Managers to Testify Before Congress on July 23
Wednesday, 10 July 2024, 10:44
Key Points:
July 23 Hearing: Executives from top PBMs will testify before Congress.
- Market Dominance: FTC report highlights the significant influence of PBMs in the market.
Conclusion:
Stay Informed: The imminent congressional hearing sheds light on the dominance of leading PBMs, prompting discussions on their role in the healthcare industry.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.